Skip to main content
. 2020 Dec 9;41(3):1427–1473. doi: 10.1002/med.21764

Figure 4.

Figure 4

AI/ML‐enabled improvements in the treatment of CNS diseases. DL is a subset of ML, which is a subset of AI and their applications address a wide range of challenges in CNS drug discovery and development. The application fields portrayed here are discussed in the Section 3. AI, artificial intelligence; CNS, central nervous system; DL, deep learning; ML, machine learning